Nkiruka C Atuegwu1, Mario F Perez2, Cheryl Oncken3, Erin L Mead4, Narinder Maheshwari5, Eric M Mortensen6. 1. Department of Medicine, University of Connecticut, Farmington, CT 06030, USA. Electronic address: atuegwu@uchc.edu. 2. Department of Medicine, University of Connecticut, Farmington, CT 06030, USA. Electronic address: maperez@uchc.edu. 3. Department of Medicine, University of Connecticut, Farmington, CT 06030, USA. Electronic address: oncken@uchc.edu. 4. Department of Medicine, University of Connecticut, Farmington, CT 06030, USA. Electronic address: mead@uchc.edu. 5. Department of Medicine, University of Connecticut, Farmington, CT 06030, USA. Electronic address: nmaheshwari@uchc.edu. 6. Department of Medicine, University of Connecticut, Farmington, CT 06030, USA. Electronic address: mortensen@uchc.edu.
Abstract
BACKGROUND: The use of e-cigarettes is increasing in the US but there is still a paucity of research on the metabolic effects of e-cigarette use. The goal of this work was to determine the association between e-cigarette use and self-reported prediabetes in adult never cigarette smokers. METHOD: The 2017 cross sectional Behavioral Risk Factor Surveillance System (BRFSS) survey data was used for the analysis. Current e-cigarette users reported daily or someday use of e-cigarettes and former e-cigarette users reported no current use of e-cigarettes. Participants who reported a history of diabetes, gestational prediabetes/ diabetes were excluded. Odds ratios were calculated to determine the association between e-cigarette use and self-reported prediabetes in never cigarette smokers after adjusting for potential confounders. RESULTS: There were a total of 154,404 participants that met the inclusion criteria. Of those participants, there were 143,952 never, 1339 current and 7625 former e-cigarette users. Current e-cigarette users had an increased odds of reporting a diagnosis of prediabetes 1.97 (95% CI 1.25-3.10) compared to never e-cigarette users. After stratifying by gender, men and women had an increased odds ratio of reporting a diagnosis of prediabetes 2.36 (95% CI 1.26-4.40) and 1.88 (95% CI 1.00-3.53) respectively when compared to never e-cigarette users. There was no association between former e-cigarette use and a self-reported diagnosis of prediabetes. CONCLUSION: Our findings show that e-cigarette use may be associated with self-reported prediabetes. Further evaluation is needed in prospective studies.
BACKGROUND: The use of e-cigarettes is increasing in the US but there is still a paucity of research on the metabolic effects of e-cigarette use. The goal of this work was to determine the association between e-cigarette use and self-reported prediabetes in adult never cigarette smokers. METHOD: The 2017 cross sectional Behavioral Risk Factor Surveillance System (BRFSS) survey data was used for the analysis. Current e-cigarette users reported daily or someday use of e-cigarettes and former e-cigarette users reported no current use of e-cigarettes. Participants who reported a history of diabetes, gestational prediabetes/ diabetes were excluded. Odds ratios were calculated to determine the association between e-cigarette use and self-reported prediabetes in never cigarette smokers after adjusting for potential confounders. RESULTS: There were a total of 154,404 participants that met the inclusion criteria. Of those participants, there were 143,952 never, 1339 current and 7625 former e-cigarette users. Current e-cigarette users had an increased odds of reporting a diagnosis of prediabetes 1.97 (95% CI 1.25-3.10) compared to never e-cigarette users. After stratifying by gender, men and women had an increased odds ratio of reporting a diagnosis of prediabetes 2.36 (95% CI 1.26-4.40) and 1.88 (95% CI 1.00-3.53) respectively when compared to never e-cigarette users. There was no association between former e-cigarette use and a self-reported diagnosis of prediabetes. CONCLUSION: Our findings show that e-cigarette use may be associated with self-reported prediabetes. Further evaluation is needed in prospective studies.
Authors: Robert C McMillen; Mark A Gottlieb; Regina M Whitmore Shaefer; Jonathan P Winickoff; Jonathan D Klein Journal: Nicotine Tob Res Date: 2014-11-06 Impact factor: 4.244
Authors: Jennifer L Pearson; Amanda Richardson; Raymond S Niaura; Donna M Vallone; David B Abrams Journal: Am J Public Health Date: 2012-07-19 Impact factor: 9.308
Authors: Maciej L Goniewicz; Danielle M Smith; Kathryn C Edwards; Benjamin C Blount; Kathleen L Caldwell; Jun Feng; Lanqing Wang; Carol Christensen; Bridget Ambrose; Nicolette Borek; Dana van Bemmel; Karen Konkel; Gladys Erives; Cassandra A Stanton; Elizabeth Lambert; Heather L Kimmel; Dorothy Hatsukami; Stephen S Hecht; Raymond S Niaura; Mark Travers; Charles Lawrence; Andrew J Hyland Journal: JAMA Netw Open Date: 2018-12-07
Authors: Qing C Zhang; Elizabeth A Courtney-Long; Lisa B Sinclair; Sierra Reese; Brian S Armour; Stuart K Shapira Journal: Disabil Health J Date: 2021-08-08 Impact factor: 2.554
Authors: Nkiruka C Atuegwu; Mark D Litt; Suchitra Krishnan-Sarin; Reinhard C Laubenbacher; Mario F Perez; Eric M Mortensen Journal: Int J Environ Res Public Health Date: 2021-05-20 Impact factor: 3.390
Authors: Nkiruka C Atuegwu; Cheryl Oncken; Reinhard C Laubenbacher; Mario F Perez; Eric M Mortensen Journal: Int J Environ Res Public Health Date: 2020-10-05 Impact factor: 3.390